daunorubicin has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mező, G; Oláh-Szabó, R; Pethő, L | 1 |
| Bogush, T; Robert, J; Shubina, I; Smirnova, G; Syrkin, A | 1 |
2 other study(ies) available for daunorubicin and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Influence of the Drug Position on Bioactivity in Angiopep-2-Daunomycin Conjugates.
Topics: Animals; Blood-Brain Barrier; Cell Line, Tumor; Cytostatic Agents; Daunorubicin; Drug Delivery Systems; Glioblastoma; Humans; Peptides; Rats | 2023 |
Direct evaluation of intracellular accumulation of free and polymer-bound anthracyclines.
Topics: Animals; Binding Sites; Bisbenzimidazole; Carcinoma; Cell Division; Cyanoacrylates; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Carriers; Drug Compounding; Drug Delivery Systems; Female; Glioblastoma; Humans; Leukemia, Erythroblastic, Acute; Ovarian Neoplasms; Polyglutamic Acid; Polymers; Rats; Tumor Cells, Cultured | 1995 |